Richard Glynne

Chief Executive Officer at

Belharra Therapeutics, Inc.

Health Technology

Commercial Services

Finance

Profile

Dr. Richard Glynne is a Chief Executive Officer at Belharra Therapeutics, Inc., a CSO at Inception Sciences, Inc. and a Venture Partner at Versant Venture Management LLC.
Dr. Glynne was previously employed as an Associate by NewCo /Ca/, an Executive Director by Novartis Institutes for Biomedical Research, Inc., an Executive Director of Genetics by Novartis AG, a VP Genetics by Phenomix Corp., and a Director Genomics by EOS Biotechnology, Inc. He received his doctorate degree from Imperial Cancer Research Fund Trading Ltd..

Richard Glynne active positions

Companies	Position	Start
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements.	Private Equity Investor	01/01/2018
Inception Sciences, Inc. Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services	Corporate Officer/Principal	01/11/2018
Belharra Therapeutics, Inc. Belharra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a ?drug discovery company	Chief Executive Officer	01/01/2025

All active positions of Richard Glynne

Former positions of Richard Glynne

Companies	Position	End
NewCo /Ca/ NewCo /Ca/ Food DistributorsDistribution Services Distributes pet food	Corporate Officer/Principal	01/11/2018
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches	Private Equity Investor	01/01/2018
NOVARTIS AG	Private Equity Investor	01/01/2015
Phenomix Corp. Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs	Private Equity Investor	01/01/2004
EOS Biotechnology, Inc. EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs	Corporate Officer/Principal	01/01/2002

See the detail of Richard Glynne's experience

Training of Richard Glynne

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Richard Glynne's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Phenomix Corp. Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
EOS Biotechnology, Inc. EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs	Health Technology
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements.	Finance
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches	Commercial Services
Imperial Cancer Research Fund Trading Ltd. Imperial Cancer Research Fund Trading Ltd. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inception Sciences, Inc. Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services	Health Technology
NewCo /Ca/ NewCo /Ca/ Food DistributorsDistribution Services Distributes pet food	Distribution Services
Belharra Therapeutics, Inc. Belharra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a ?drug discovery company	Commercial Services